CHRISTINE DEMPSEY: Open Payments
NPI 1336821214 · MANCHESTER, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,636 in 83 payments from 17 companies in 2025. Trend: 2023 $353 · 2024 $2,501 · 2025 $1,636
Food & beverage: $1,636
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $266 |
| PFIZER INC. | 17 | $263 |
| AstraZeneca Pharmaceuticals LP | 9 | $173 |
| GlaxoSmithKline, LLC. | 9 | $167 |
| Lilly USA, LLC | 9 | $134 |
| Axsome Therapeutics, Inc. | 4 | $104 |
| ILLUMINOSS MEDICAL, INC. | 1 | $95 |
| ABBVIE INC. | 4 | $81 |
| Xeris Pharmaceuticals, Inc. | 4 | $77 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $69 |
Products named: Ozempic, TRELEGY ELLIPTA, NURTEC ODT, ELIQUIS, MOUNJARO, Auvelity, Photodynamic Bone Stabilization Procedure Pack, Kerendia.
Industry payments across TN — which companies pay providers there.
